CYP2B6 Inhibitors

The chemical class of CYP2B6 Inhibitors encompasses a diverse range of compounds that can inhibit the function of the cytochrome P450 2B6 enzyme. This inhibition is crucial because CYP2B6 plays a significant role in the metabolism of various drugs, and its inhibition can lead to altered pharmacokinetics and dynamics of these drugs. The inhibitors operate through different mechanisms, but primarily, they either compete with the enzymes substrates or interfere with its catalytic activity.Clopidogrel, Ticlopidine, Thiotepa, and Cyclophosphamide are examples of drugs whose metabolites can act as inhibitors of CYP2B6. These metabolites compete with or block the active site of the enzyme, thereby inhibiting its normal function. Phenytoin, Secobarbital, and Sertraline,share the common trait of inhibiting CYP2B6, affecting its ability to metabolize other drugs. This can result in drug interactions and altered drug efficacy or toxicity. Additionally, compounds like Nevirapine, Efavirenz, Propofol, Methadone, and Ritonavir are particularly notable for their CYP2B6 inhibitory activity. These compounds are known to significantly influence the metabolic pathway of drugs processed by CYP2B6, leading to increased plasma levels of these drugs. The mechanism of inhibition can vary from direct interaction with the enzymes active site to altering its expression or stability.